COMBINATION THERAPY FOR CANCER

• 收藏
• 分享

专利权人:

CELGENE CORPORATION

发明人:

POURDEHNAD, MICHAEL,GANDHI, ANITA,TAKESHITA, KENICHI,CHOPRA, RAJESH

申请号：

SG11201700201U

公开号：

SG11201700201UA

申请日:

2015.07.10

申请国别(地区):

SG

年份:

2017

代理人:

摘要：

Provided herein are methods of treating, preventing and/or managing lymphomas and leukemias by administering to a patient Compound A (3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione), or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof, in combination with an anti-CD20 antibody or ibrutinib, or a pharmaceutically acceptable salt or solvate thereof

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/